World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
107
Citations
61755
World Ranking
538
National Ranking
21

Medicine

D-Index
107
Citations
61755
World Ranking
6117
National Ranking
233

Bart L. Haagmans publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Bart L. Haagmans sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 369 publications — 77th percentile

77% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Bart L. Haagmans D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Bart L. Haagmans sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 107 D-Index — 89th percentile

89% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Research.com Recognitions

  • 2022 - European Society for Clinical Microbiology and Infectious Diseases Excellence Award

Overview

Bart L. Haagmans is affiliated with Erasmus University Rotterdam in the Netherlands. Their primary field of study is Medicine with a specialized focus on Infectious Diseases, Epidemiology, Animal Science and Zoology, Molecular Biology, and Modeling and Simulation. The scientist has contributed extensively to research on SARS-CoV-2 and COVID-19, encompassing studies on COVID-19 clinical research, SARS-CoV-2 detection and testing, animal virus infections, respiratory viral infections, viral gastroenteritis, and COVID-19 epidemiological studies.

They have published numerous papers in various scientific venues, with frequent publications appearing in:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Nature Communications
  • Nature Medicine
  • Science Immunology
  • Science

Notable recent papers authored or co-authored by the scientist include:

  • Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR, 2020, Eurosurveillance
  • The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2, 2020, Nature Microbiology
  • Severe Acute Respiratory Syndrome Coronavirus 2−Specific Antibody Responses in Coronavirus Disease Patients, 2020, Emerging infectious diseases
  • SARS-CoV-2 productively infects human gut enterocytes, 2020, Science
  • Severe acute respiratory syndrome-related coronavirus: The species and its viruses - a statement of the Coronavirus Study Group, 2020, bioRxiv (Cold Spring Harbor Laboratory)

Bart L. Haagmans collaborates frequently with a number of co-authors in their research. Key collaborators include:

  • Mart M. Lamers
  • Marion Koopmans
  • Anna Z. Mykytyn
  • Nisreen M.A. Okba
  • Corine H. GeurtsvanKessel

The scientist's research topics cover a broad range of subjects related to viral infectious diseases with a significant emphasis on the SARS-CoV-2 virus and the COVID-19 pandemic. Their work includes studies on detection and testing techniques, clinical research into COVID-19 patient responses, investigations into animal virus infections, as well as epidemiological analyses of outbreaks.

In recognition of their contributions, Bart L. Haagmans received the European Society for Clinical Microbiology and Infectious Diseases Excellence Award in 2022.

Best Publications

  • Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR.

    Victor M. Corman;Olfert Landt;Marco Kaiser;Richard Molenkamp

  • The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2

    Alexander E. Gorbalenya;Susan C. Baker;Ralph S. Baric;Raoul J. de Groot

  • Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC

    V. Stalin Raj;Huihui Mou;Saskia L. Smits;Dick H. W. Dekkers

  • Severe acute respiratory syndrome-related coronavirus: The species and its viruses – a statement of the Coronavirus Study Group

    Alexander E. Gorbalenya;Alexander E. Gorbalenya;Susan C. Baker;Ralph Baric;Raoul J. de Groot

  • SARS-CoV-2 productively infects human gut enterocytes.

    Mart M. Lamers;Joep Beumer;Jelte van der Vaart;Kèvin Knoops

  • Severe Acute Respiratory Syndrome Coronavirus 2-Specific Antibody Responses in Coronavirus Disease Patients

    Nisreen M.A. Okba;Marcel A. Müller;Wentao Li;Chunyan Wang

  • A human monoclonal antibody blocking SARS-CoV-2 infection.

    Chunyan Wang;Wentao Li;Dubravka Drabek;Nisreen M.A. Okba

  • Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability.

    Philip J. M. Brouwer;Tom G. Caniels;Karlijn van der Straten;Jonne L. Snitselaar

  • Genomic Characterization of a Newly Discovered Coronavirus Associated with Acute Respiratory Distress Syndrome in Humans

    Sander van Boheemen;Miranda de Graaf;Chris Lauber;Theo M. Bestebroer

  • Comparative pathogenesis of COVID-19, MERS, and SARS in a nonhuman primate model.

    Barry Rockx;Thijs Kuiken;Sander Herfst;Theo Bestebroer

  • SARS-CoV-2 pathogenesis

    Unknown

  • Phenotype and kinetics of SARS-CoV-2-specific T cells in COVID-19 patients with acute respiratory distress syndrome.

    Daniela Weiskopf;Katharina S. Schmitz;Matthijs P. Raadsen;Alba Grifoni

  • Middle East respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels: a comparative serological study

    Chantal B.E.M. Reusken;Bart L. Haagmans;Marcel A. Müller;Carlos Gutierrez

  • Animal models for COVID-19.

    César Muñoz-Fontela;William E. Dowling;Simon G.P. Funnell;Pierre S. Gsell

  • Middle East respiratory syndrome coronavirus in dromedary camels: An outbreak investigation

    Bart L. Haagmans;Said H.S. Al Dhahiry;Chantal B.E.M. Reusken;V. Stalin Raj

  • Duration and key determinants of infectious virus shedding in hospitalized patients with coronavirus disease-2019 (COVID-19).

    Jeroen J. A. van Kampen;David A. M. C. van de Vijver;Pieter L. A. Fraaij;Bart L. Haagmans

  • Virology: SARS virus infection of cats and ferrets.

    Byron E. E. Martina;Bart L. Haagmans;Thijs Kuiken;Ron A. M. Fouchier

  • Exosome-mediated transmission of hepatitis C virus between human hepatoma Huh7.5 cells

    Vedashree Ramakrishnaiah;Christine Thumann;Isabel Fofana;Francois Habersetzer

  • SARS-CoV-2 variants of concern partially escape humoral but not T-cell responses in COVID-19 convalescent donors and vaccinees.

    Daryl Geers;Marc C Shamier;Susanne Bogers;Gerco den Hartog

  • The emerging role of ACE2 in physiology and disease

    Inge Hamming;M. E. Cooper;B. L. Haagmans;N. M. Hooper

  • Pegylated interferon-alpha protects type 1 pneumocytes against SARS coronavirus infection in macaques.

    Bart L. Haagmans;Thijs Kuiken;Byron Ee E Martina;Ron Am M Fouchier

  • Assays for laboratory confirmation of novel human coronavirus (hCoV-EMC) infections.

    Victor Corman;Marcel Müller;U. Costabel;J. Timm

Frequent Co-Authors

Albert D. M. E. Osterhaus
Albert D. M. E. Osterhaus University of Veterinary Medicine Hannover, Foundation
Marion Koopmans
Marion Koopmans Erasmus University Rotterdam
V. Stalin Raj
V. Stalin Raj Erasmus University Rotterdam
Berend Jan Bosch
Berend Jan Bosch Utrecht University
Chantal Reusken
Chantal Reusken National Institute of Public Health and the Environment (RIVM)
Theo M. Bestebroer
Theo M. Bestebroer Erasmus University Rotterdam
Thijs Kuiken
Thijs Kuiken Erasmus University Rotterdam
Ron A. M. Fouchier
Ron A. M. Fouchier Erasmus University Rotterdam
Marian C. Horzinek
Marian C. Horzinek Utrecht University
Suzan D. Pas
Suzan D. Pas Radboud University Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in Immunology, exploring related healthcare fields can open diverse career opportunities. Many pursue nursing paths that complement Immunology knowledge, such as becoming a Nurse Practitioner with specialized expertise.

One popular route is to transition within nursing specialties. For those already licensed as Family Nurse Practitioners, advanced training through acnp programs can shift careers toward acute care settings, enhancing clinical skill sets in immunological and critical care contexts.

Applicants without a nursing background can still enter the field through pathways like online adn programs for non nurses, designed to build foundational clinical knowledge efficiently while accommodating non-traditional students.

For those looking to accelerate their nursing careers, accelerated nurse practitioner programs offer a fast-track to advanced practice roles, integrating critical immunology coursework vital for patient care in infectious and autoimmune diseases.

Furthermore, students seeking straightforward admissions can explore easiest absn programs to get into, providing quicker pathways to obtain a BSN degree and advance toward immunology-related healthcare careers.

Best Scientists Citing Bart L. Haagmans

Trending Scientists